Maltas, Jeff http://orcid.org/0000-0001-6567-6800
Killarney, Shane T. http://orcid.org/0000-0002-8471-6641
Singleton, Katherine R.
Strobl, Maximilian A. R. http://orcid.org/0000-0003-4484-8823
Washart, Rachel
Wood, Kris C. http://orcid.org/0000-0002-5887-2253
Wood, Kevin B. http://orcid.org/0000-0002-0985-7401
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35GM124875, T32 GM007171)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA207083, R01CA263593)
Article History
Received: 6 July 2022
Accepted: 19 October 2023
First Online: 27 November 2023
Change Date: 12 December 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41559-023-02300-9
Competing interests
: K.C.W. is a founder, consultant and equity holder at Tavros Therapeutics and Celldom and has performed consulting work for Guidepoint Global, Bantam Pharmaceuticals and Apple Tree Partners. All other authors declare no competing interests.